Access to anti-retroviral drugs, male in Belgium
Belgium: Access to anti-retroviral drugs, male was 88.0% in 2023. ▲ Rising
Access to anti-retroviral drugs, male in Belgium, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
In 2023, access to anti-retroviral drugs, male in Belgium stood at 88.0%.
That represents a change of up 8.6% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Belgium peaked at 90.0% in 2018 and was at its lowest, 37.0%, in 2000.
Belgium ranks 23rd of 141 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 24 years of available data.
Access to anti-retroviral drugs, male in Belgium, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 37.0% | — |
| 2001 | 40.0% | +8.1% |
| 2002 | 43.0% | +7.5% |
| 2003 | 45.0% | +4.7% |
| 2004 | 46.0% | +2.2% |
| 2005 | 48.0% | +4.3% |
| 2006 | 56.0% | +16.7% |
| 2007 | 59.0% | +5.4% |
| 2008 | 63.0% | +6.8% |
| 2009 | 68.0% | +7.9% |
| 2010 | 74.0% | +8.8% |
| 2011 | 80.0% | +8.1% |
| 2012 | 77.0% | -3.8% |
| 2013 | 81.0% | +5.2% |
| 2014 | 83.0% | +2.5% |
| 2015 | 86.0% | +3.6% |
| 2016 | 88.0% | +2.3% |
| 2017 | 89.0% | +1.1% |
| 2018 | 90.0% | +1.1% |
| 2019 | 88.0% | -2.2% |
| 2020 | 87.0% | -1.1% |
| 2021 | 88.0% | +1.1% |
| 2022 | 88.0% | +0.0% |
| 2023 | 88.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 50.5% | 37.0% | 68.0% | 10 |
| 2010s | 83.6% | 74.0% | 90.0% | 10 |
| 2020s | 87.8% | 87.0% | 88.0% | 4 |
Countries ranked near Belgium
More gender data for Belgium
- Child population (UN estimates and projections) 1,701 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.52 % change on previous year (2030)
- Population 10,123 (2030)
- Working-age population (UN estimates and projections) 10,123 (2030)
- Population (UN estimates and projections), annual growth rate 0.3629 % change on previous year (2030)
- Age population, age 00, female, interpolated 49,723 (2025)
- Age population, age 00, male, interpolated 52,153 (2025)
- Age population, age 01, female, interpolated 50,100 (2025)
- Age population, age 01, male, interpolated 52,519 (2025)
- Age population, age 02, female, interpolated 53,460 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Belgium?
- Access to anti-retroviral drugs, male in Belgium was 88.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Belgium?
- The highest recorded value was 90.0% in 2018.
- What is the lowest access to anti-retroviral drugs, male recorded in Belgium?
- The lowest recorded value was 37.0% in 2000.
- How does Belgium rank for access to anti-retroviral drugs, male?
- Belgium ranks 23rd out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, male rising or falling in Belgium?
- Over the last ten years it is up 8.6%. The long-run trend across the full record is rising.
- Where does this Belgium data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.